The company was established in North America in United States. The main office of represented VC is situated in the New York.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Service Industry, Genetics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Mendel Biotechnology, eFrenzy
The increased amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2007. The fund is generally included in less than 2 deals every year.
We also calculated 4 valuable employees in our database.
The standard case for the fund is to invest in rounds with 5-6 partakers. The meaningful sponsors for the fund in investment in the same round are iXL, Trinity Ventures, Tribune Ventures.
Related Funds
Funds with similar focus
Fund Name | Location |
Alexion Pharmaceuticals | Cheshire, Connecticut, United States |
Amrest | Finland, Minnesota, United States |
Cass Business School | England, London, United Kingdom |
Delta Drone | Auvergne-Rhône-Alpes, France, Rhone-Alpes |
Future Home Capital | - |
Greencoat Capital | England, London, United Kingdom |
Japan Property Management Center | Japan, Tokyo |
KBL European Private Bankers | Luxembourg, Luxembourg |
Kyodo News Digital | Chiba Prefecture, Japan, Tateyama |
Lamphere Capital | New York, New York, United States |
Maersk Line | Copenhagen, Denmark, Hovedstaden |
MorphoSys | Bayern, Germany, Planegg |
NantWorks | California, Culver City, United States |
NHN JAPAN | Japan, Tokyo |
Redalpine Venture Partners | Switzerland, Zürich, Zurich |
Stride.VC | England, London, United Kingdom |
Swastika | China, Hong Kong, Hong Kong Island |
Tata Opportunities Fund (TOF) | India, Maharashtra, Mumbai |
Vireo Ventures | Berlin, Berlin, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.